Digital content for Pharmathen SA

PharmaCompass

Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Related CompaniesRelated Companies

About

Pharmathen, established in 1969, has emerged as a leading in-house development partner in Europe. It specializes in the development, registration, manufacturing & life-cycle management of complex pharmaceutical technologies & generic formulations. With a portfolio of over 100 products, Pharmathen serves over 250 clients across 80 countries. It’s pipeline includes advanced long-acting injectables, sustained-release formulations & preservative-free ophthalmics manufactured in USFDA & EU-approved facilities. Pharmathen’s core technology platforms, including microspheres, nanosuspensions & nanogels, are used to develop long-acting therapies.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Greece
Address
Address
44, Kifissias Avenue, 15125 Marousi Attica
Telephone
Telephone
+30 2106604300
Twitter
Twitter
Contact Info
Others

Events

Webinars & Exhibitions

CPhI India 2024

CPhI India 2024

Not Confirmed

envelop Contact Supplier

CPhI India 2024

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/pharmathen-sa-party-content-90525.pdf

    https://www.pharmacompass.com/pdf/party/content/pharmathen-sa-party-content-74862.pdf

    https://www.pharmacompass.com/pdf/party/content/pharmathen-sa-party-content-27922.pdf

    https://www.pharmacompass.com/pdf/party/content/pharmathen-sa-party-content-95096.pdf

    https://www.pharmacompass.com/pdf/party/content/pharmathen-sa-party-content-7582.pdf

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmathen.com/news/Pharmathen-fully-equips-the-new-scientific-laboratory-of-the-3rd-Gymnasium-of-Gerakas

PRESS RELEASE
29 Feb 2024
Pharmathen acquires CBL Patras
Pharmathen acquires CBL Patras

11 Jun 2023

// PRESS RELEASE

https://www.pharmathen.com/news/pharmathen-acquires-cbl-patras

PRESS RELEASE
11 Jun 2023

https://www.pharmathen.com/news/press-release-growth-awards-2022

PRESS RELEASE
03 Nov 2022

https://www.juve-patent.com/news-and-stories/cases/dutch-court-halts-sale-of-pharmathen-cancer-drug-okrodin-in-europe/

Joshua Silverwood JUVE
23 Aug 2022

https://www.pharmathen.com/group-ceo-article-kathimerini-08.2022

PRESS RELEASE
08 Aug 2022

https://www.pharmathen.com/press-release-pharmathen-04.2022

PRESS RELEASE
08 Apr 2022

01

Aprepitant

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AAPS 2024
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Pharmathen

02

Brinzolamide

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AAPS 2024
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Pharmathen

03

Fluvastatin Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AAPS 2024
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Pharmathen

04

Paliperidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AAPS 2024
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Pharmathen

05

Valganciclovir Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AAPS 2024
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Pharmathen

06

Voriconazole

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AAPS 2024
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Pharmathen
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

On acquisition, Partners Group will work to strengthen Pharmathen’s business in Europe and the US, especially R&D, sustained release’ technologies, including long-acting injectables, slow-releasing oral drugs and ophthalmics segment.


Lead Product(s): Undisclosed

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Small molecule

Sponsor: Partners Group

Deal Size: $1,900.0 million Upfront Cash: Undisclosed

Deal Type: Acquisition July 19, 2021

Pharmathen

01

Pharmathen SA

Greece
arrow
AAPS 2024
Not Confirmed

Lead Product(s) : Undisclosed

Therapeutic Area : Ophthalmology

Highest Development Status : Undisclosed

Partner/Sponsor/Collaborator : Partners Group

Deal Size : $1,900.0 million

Deal Type : Acquisition

Details : On acquisition, Partners Group will work to strengthen Pharmathen’s business in Europe and the US, especially R&D, sustained release’ technologies, including long-acting injectables, slow-releasing oral drugs and ophthalmics segment.

Brand Name : Undisclosed

Molecule Type : Small molecule

Upfront Cash : Undisclosed

July 19, 2021

Pharmathen
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Brand Name : N/A

Pharmathen SA

Dosage Form : Tablet

Brand Name :

Dosage Strength : 70MG; 5600IU

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

02

Brand Name : N/A

Pharmathen SA

Dosage Form : Tablet

Brand Name :

Dosage Strength : 70MG; 2800IU

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

03

Brand Name : N/A

Pharmathen SA

Dosage Form : Hard Capsule

Brand Name :

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

04

Brand Name : N/A

Pharmathen SA

Dosage Form : Hard Capsule

Brand Name :

Dosage Strength : 165MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

05

Brand Name : N/A

Pharmathen SA

Dosage Form : Injectable Emulsion, For...

Brand Name :

Dosage Strength : 130MG

Packaging : Single Dose Vial

Approval Date :

Application Number :

Regulatory Info : USA

Registration Country : Greece

Pharmathen

06

Brand Name : N/A

Pharmathen SA

Dosage Form : Hard Capsule

Brand Name :

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

07

Brand Name : N/A

Pharmathen SA

Dosage Form : Hard Capsule

Brand Name :

Dosage Strength : 125MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

08

Brand Name : N/A

Pharmathen SA

Dosage Form : Orodispersible Tablet

Brand Name :

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

09

Brand Name : N/A

Pharmathen SA

Dosage Form : Orodispersible Tablet

Brand Name :

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

10

Brand Name : N/A

Pharmathen SA

Dosage Form : Tablet

Brand Name :

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Check the inspections & registration from this company

EDQM

read-more
read-more

01

GMP Certified

EU

Pharmathen SA

Type : GMP Certificates

Number : 141425/ 21-...

EudraGMDP Key : 143464

Country : Greece

Issue Date : 2022-01-13

Post Code : 15351

NCA Ref : 0000006501

City : Pallini Attiki

Pharmathen

02

GMP Certified

EU

Pharmathen SA

Type : GMP Certificates

Number : 323129/ 31-...

EudraGMDP Key : 160514

Country : Greece

Issue Date : 2023-05-10

Post Code : 693 00

NCA Ref : 166201371247...

City : Sapes

Pharmathen
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

GDUFA

read-more
read-more

01

GDUFA fees paid

USA
arrow
AAPS 2024
Not Confirmed

API Manufacturer :

FDF Manufacturer : FDF MANUFACTURE

Facility Name : Pharmathen International S.A.

Business Address : Industrial Park, Building Bl...

FEI Number : 3009961173

Country : Greece

Paid in : 2024

Pharmathen
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact Pharmathen SA and get a quotation

Pharmathen SA is a supplier offers 6 products (APIs, Excipients or Intermediates).

Find a price of Aprepitant bulk with DMF offered by Pharmathen SA

Find a price of Brinzolamide bulk with DMF offered by Pharmathen SA

Find a price of Fluvastatin Sodium bulk with DMF offered by Pharmathen SA

Find a price of Paliperidone bulk with DMF offered by Pharmathen SA

Find a price of Valganciclovir Hydrochloride bulk with DMF offered by Pharmathen SA

Find a price of Voriconazole bulk with DMF offered by Pharmathen SA

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty